Medications for Precursor Bcell Lymphoblastic Leukemia

1 result
  • tecartus

    (Brexucabtagene Autoleucel)
    Kite Pharma, Inc.
    Tecartus is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory mantle cell lymphoma (MCL) or relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).